Metraipolis › archive › dc_ddda3194a99d
Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review… — Europe PMC PMID:40901275
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40901275
- DOI
- 10.7759/cureus.91432
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:59:14.552Z
- SHA-256 of the archived text
805ff83b7fa7b860459472d7dbfa032c038a865256f6d04f5a9c096fb282863c- Stable URL of this page
https://metraipolis.com/documento/dc_ddda3194a99d
How to cite
Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review… — Europe PMC PMID:40901275 — Europe PMC (en), https://europepmc.org/article/MED/40901275 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ddda3194a99d (Metraipolis archive dc_ddda3194a99d, sha256 805ff83b7fa7b860459472d7dbfa032c038a865256f6d04f5a9c096fb282863c)
BibTeX
@misc{dcddda3194a99d,
title = {Efficacy and Safety of Vildagliptin Versus Other Dipeptidyl Peptidase 4 (DPP-4) Inhibitors in the Management of Type 2 Diabetes Mellitus: A Systematic Review… — Europe PMC PMID:40901275},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40901275},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ddda3194a99d; sha256 805ff83b7fa7b860459472d7dbfa032c038a865256f6d04f5a9c096fb282863c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40901275. Agents can read the archived copy with the MCP tool read_document.